Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 38
Selected: 0
NCT IDTitle
NCT02600494Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression
NCT03249376Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
NCT05850689Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05732194Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers
NCT06651567A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
NCT05470101A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects
NCT01499563Study of a Novel Antipsychotic ITI-007 in Schizophrenia
NCT06462612Study of Lumateperone in the Treatment of Patients With Bipolar Mania
NCT03257046Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease
NCT03489772Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement
NCT02078310Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
NCT06299410PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects
NCT04709224Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia
NCT04934124Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers
NCT05061719An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT06174116Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
NCT06229210Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia or Bipolar Disorder
NCT06462586Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania
NCT02469155A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
NCT06627413Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder
NCT05061706Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05766813Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
NCT02817906ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease
NCT05356013Caplyta in Borderline Personality Disorder
NCT06372964Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
NCT06557902Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder
NCT03387215Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure
NCT02600507Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
NCT04959032Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
NCT04285515Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder
NCT02282761A Trial to Assess the Antipsychotic Efficacy of ITI-007
NCT03817528ITI-007 (Lumateperone Tosylate) for Schizophrenia
NCT06480383Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
NCT02288845Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia
NCT01900522Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia
NCT04985942Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT04779177Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder
NCT06540833A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease